Katie Peterson
About Katie Peterson
Katie Peterson serves as the Head of FP&A at Wave Life Sciences, a position she has held since 2020. She has a background in finance and accounting, with previous roles at Merrimack Pharmaceuticals, Ernst & Young, and Spero Therapeutics.
Work at Wave Life Sciences
Katie Peterson has served as the Head of Financial Planning and Analysis (FP&A) at Wave Life Sciences since 2020. In this role, she oversees the financial planning processes, including budgeting, forecasting, and financial reporting. Her leadership contributes to the strategic financial direction of the company, ensuring alignment with its business objectives.
Previous Experience in Finance
Before joining Wave Life Sciences, Katie Peterson worked at Spero Therapeutics as a Financial Planning and Analysis professional from 2016 to 2020. Prior to that, she spent five years at Merrimack Pharmaceuticals in accounting and finance roles from 2011 to 2016. Additionally, she served as an Assurance Manager at Ernst & Young from 2005 to 2011, gaining extensive experience in financial oversight and compliance.
Educational Background
Katie Peterson completed her Bachelor of Arts in Economics at Providence College from 2001 to 2005. She furthered her education by obtaining a Master of Science in Accountancy from the University of Notre Dame, studying there from 2005 to 2006. Earlier, she graduated from La Salle Academy, completing her high school education from 1997 to 2001.